Literature DB >> 24760600

Influence of training status and eNOS haplotypes on plasma nitrite concentrations in normotensive older adults: a hypothesis-generating study.

Roberta Fernanda da Silva1, Jonas Tadeu Cau Sertório, Riccardo Lacchini, Atila Alexandre Trapé, José Eduardo Tanus-Santos, James W E Rush, Sandra Lia Amaral, Anderson Saranz Zago.   

Abstract

The purpose of this study was to evaluate the relationship between 3 eNOS gene polymorphisms and training status (TS) in affecting plasma nitrite concentration (NO2) in normotensive adults over 50 years old. Resting blood pressure (BP) was measured in all participants (n = 101). Plasma was taken to analyze: lipid profile, nitrite concentration (NO2) and lipid peroxide levels (T-BARS). Also, genomic DNA was extracted from plasma for genotyping NOS3 polymorphisms (-786T>C; 894G>T; and VNTR in intron 4). TS was determined by one-mile walk test and Functional Fitness Test Battery from AAHPERD (TS1-regular TS; TS2-good TS; and TS3-very good TS). BP was not influenced by TS, but NO2 was 15% higher in TS3 (123 ± 27 nM) compared to TS-2 (106 ± 22 nM). No differences were found in plasma NO2 in the haplotype analyses. However, the presence of the C allele (T-786C) and ASP allele (Glu298Asp) was found to enhance the correlation between TS and NO2 levels (r = 0.492 in C/4b/ASP haplotype and r = 0.855 in C/4a/ASP haplotype). This study thus identifies NOS3 polymorphism-dependent sensitivity to the effects of physical training on plasma NO2. Maintenance of good levels of training status, in carriers of C allele for T-786C polymorphism, combined with ASP allele for Glu298Asp polymorphism, may result in an increase in the NO2 plasma concentrations, which may reflect improved NO bioavailability in older adult normotensive individuals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760600     DOI: 10.1007/s40520-014-0218-y

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  4 in total

1.  Age and gender differences in the influences of eNOS T-786C polymorphism on arteriosclerotic parameters in general population in Japan.

Authors:  Marowa Hashimoto; Nobuyuki Miyai; Sonomi Hattori; Akihiko Iwahara; Miyoko Utsumi; Mikio Arita; Tatsuya Takeshita
Journal:  Environ Health Prev Med       Date:  2016-04-01       Impact factor: 3.674

2.  NOS3 Polymorphisms Can Influence the Effect of Multicomponent Training on Blood Pressure, Nitrite Concentration and Physical Fitness in Prehypertensive and Hypertensive Older Adult Women.

Authors:  Átila Alexandre Trapé; Jhennyfer Aline Lima Rodrigues; Letícia Perticarrara Ferezin; Gustavo Duarte Ferrari; Elisangela Aparecida da Silva Lizzi; Vitor Nolasco de Moraes; Roberta Fernanda da Silva; Anderson Saranz Zago; Javier Brazo-Sayavera; Carlos Roberto Bueno Júnior
Journal:  Front Physiol       Date:  2021-03-10       Impact factor: 4.566

3.  Effect of Multicomponent Training on Blood Pressure, Nitric Oxide, Redox Status, and Physical Fitness in Older Adult Women: Influence of Endothelial Nitric Oxide Synthase (NOS3) Haplotypes.

Authors:  Atila Alexandre Trapé; Elisangela Aparecida da Silva Lizzi; Thiago Correa Porto Gonçalves; Jhennyfer Aline Lima Rodrigues; Simone Sakagute Tavares; Riccardo Lacchini; Lucas Cezar Pinheiro; Graziele Cristina Ferreira; José Eduardo Tanus-Santos; Paula Payão Ovídio; Alceu Afonso Jordão; André Mourão Jacomini; Anderson Saranz Zago; Carlos Roberto Bueno Júnior
Journal:  Oxid Med Cell Longev       Date:  2017-09-14       Impact factor: 6.543

4.  Association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and physical fitness levels with plasma nitrite concentrations and arterial blood pressure values in older adults.

Authors:  Roberta Fernanda da Silva; Átila Alexandre Trapé; Thaís Amanda Reia; Riccardo Lacchini; Gustavo Henrique Oliveira-Paula; Lucas Cezar Pinheiro; José Eduardo Tanus-Santos; André Mourão Jacomini; Carlos Roberto Bueno Júnior; Anderson Saranz Zago
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.